Encompass Health Corp operates as a leading integrated healthcare services provider. The company's business model primarily focuses on offering post-acute healthcare services and rehabilitation therapies. With a network of inpatient rehabilitation hospitals, home health agencies, and hospice agencies, Encompass Health aims to provide high-quality, personalized care to patients recovering from illnesses, injuries, or surgeries. Through its interdisciplinary approach, advanced technologies, and clinical expertise, Encompass Health Corp strives to improve patients' health outcomes and enhance their overall quality of life.

Encompass Health Corp is primarily active in the healthcare industry.

Encompass Health Corp faces competition from various companies in the market. Some of its main competitors include Kindred Healthcare, Select Medical Holdings Corporation, and HealthSouth Corporation.

Encompass Health Corp, formerly known as HealthSouth Corporation, is a leading provider of integrated healthcare services in the United States. Founded in 1984, the company has a rich history and a strong background in rehabilitation and home health services. Encompass Health Corp offers a wide range of services, including inpatient rehabilitation, outpatient care, and home health services across various settings. With a commitment to delivering high-quality care and improving patients' lives, Encompass Health Corp has grown to become one of the largest post-acute healthcare providers in the country, serving thousands of patients annually. The company's dedication to innovation and excellence has earned it a solid reputation in the healthcare industry.

Encompass Health Corp has achieved several significant milestones over the years. Firstly, the company expanded its operations and became the leading provider of integrated post-acute healthcare services in the United States. Furthermore, they successfully rebranded their name from HealthSouth Corporation to Encompass Health Corp in 2018, showcasing their commitment to comprehensive and innovative care. Encompass Health Corp has consistently ranked among Fortune 500 companies and has received recognition for its quality patient care and clinical outcomes. Additionally, the company continues to grow its network of hospitals, home health agencies, and hospice centers, ensuring a broad range of services to meet patients' evolving needs.

Encompass Health Corp is primarily present in the United States.

Encompass Health Corp represents a strong emphasis on patient-centered care and providing high-quality, compassionate healthcare services. The company's values revolve around integrity, excellence, collaboration, and compassion. Encompass Health Corp is dedicated to delivering innovative healthcare solutions and improving the lives of patients through personalized care plans and advanced medical technologies. With a focus on positive patient outcomes, the company strives to continually enhance its services, expand its reach, and contribute positively to the communities it serves. Encompass Health Corp's corporate philosophy centers on delivering exceptional care with a commitment to clinical excellence, integrity, and respect for individuals.

Analysts currently set an average price target of 143.14 USD for the Encompass Health stock (median: 142.80 USD), implying +27.6 % versus the latest price. The consensus is based on 16 analyst ratings.

Encompass Health Analyst Price Targets 2026

16 analysts currently rate the Encompass Health stock: 15 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Encompass Health to generate revenue of 6.49 B USD and earnings per share of 5.87 USD.

Encompass Health Analyst Price Targets 2026

Converted at the current exchange rate, the Encompass Health share trades at 98.52 EUR (112.50 USD).

The Encompass Health share (EHC) is listed on 2 stock exchanges, including: NYSE (EHC), Frankfurt (HSOA.F).

Encompass Health Corp is a leading provider of rehabilitation services in the United States. The company operates 140 hospitals, rehabilitation centers, and home health services in 39 states, serving millions of patients annually. The company's business model focuses on offering a comprehensive range of rehabilitation services, including hospital rehabilitation, in-patient rehabilitation, in-home healthcare, and long-term care. Encompass Health's services aim to restore patients' independence and mobility, improving their quality of life. The company offers a wide range of treatments, including therapy, rehabilitation, and nursing care, and utilizes modern technologies such as robots to assist patients. Collaboration with insurance companies and government agencies is an important part of Encompass Health's business model, enabling the company to provide its services and expand access to healthcare for a broader population. In addition, the company offers specialized rehabilitation programs for patients with brain injuries, spinal cord injuries, strokes, and other neurological disorders. Encompass Health also sells medical equipment and accessories and provides electronic patient documentation and billing systems to other healthcare facilities. The company's success is attributed to its focus on a crucial niche in the healthcare industry and the increasing demand for rehabilitation services due to an aging population and the need for support after accidents and illnesses. By utilizing modern technology to achieve medical advancements and providing value-based care, Encompass Health is able to offer high-quality services to patients while maintaining a profitable business model. In summary, Encompass Health's business model is centered around providing comprehensive and coordinated rehabilitation services to patients. The company's use of modern technology and partnerships with insurance companies and government agencies are key to its success. The company is well-positioned to meet the demands of the growing rehabilitation market and expand its market share.

The expected revenue of Encompass Health is 6.49 B USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Encompass Health is 599.78 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Encompass Health is currently 19.17. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Encompass Health stock.

The price-to-sales ratio (P/S) of Encompass Health is currently 1.77. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Encompass Health stock.

The Eulerpool Quality Score for Encompass Health is 7/10.

The ISIN of Encompass Health is US29261A1007. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Encompass Health is A2H9HM. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Encompass Health is EHC. The ticker symbol is used to trade Encompass Health shares on the stock exchange.

Over the past 12 months, Encompass Health paid a dividend of 0.47 USD . This corresponds to a dividend yield of about 0.42 %. For the coming 12 months, Encompass Health is expected to pay a dividend of 0.72 USD.

The current dividend yield of Encompass Health is 0.42 %.

Encompass Health pays a dividend, distributed in the months of , , , .

Encompass Health paid dividends every year for the past 13 years.

For the upcoming 12 months, dividends amounting to 0.72 USD are expected. This corresponds to a dividend yield of 0.64 %.

Encompass Health is assigned to the 'Health' sector.

In the year 2025, Encompass Health distributed 0.64 USD as dividends.

The dividends of Encompass Health are distributed in USD.